23
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      The HIV/AIDS epidemic in Cuba: description and tentative explanation of its low HIV prevalence

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          The Cuban HIV/AIDS epidemic has the lowest prevalence rate of the Caribbean region. The objective of this paper is to give an overview of the HIV/AIDS epidemic in Cuba and to explore the reasons for this low prevalence.

          Methods

          Data were obtained from the Cuban HIV/AIDS programme established in 1983. This programme has an extensive adult HIV testing policy, including testing of all pregnant women. HIV and AIDS cases have been recorded since 1986. Persons found to be HIV-positive are interviewed on their sexual behaviour and partners. Tracing and voluntary testing of these partners are organised. Epidemiological description of this epidemic was obtained from analysis of this data set. Using elementary mathematical analyses, we estimated the coverage of the detection system (percentage of HIV-positive adults detected) and the average period between HIV infection and detection. Estimated HIV prevalence rates were corrected to account for the coverage.

          Results

          HIV prevalence has increased since 1996. In 2005, the prevalence among pregnant women was 1.2 per 10,000 (16/137000). Estimated HIV prevalence among 15- to 49-year-olds was 8.1 per 10,000 (4913/6065000; 95%CI: 7.9 per 10,000 – 8.3 per 10,000). Most (77%) of the HIV-positive adults were men, most (85.1%) of the detected HIV-positive men were reported as having sex with men (MSM), and most of the HIV-positive women reported having had sex with MSM. The average period between HIV infection and detection was estimated to be 2.1 years (IQR = 1.7 – 2.2 years). We estimated that, for the year 2005, 79.6% (IQR: 77.3 – 81.4%) of the HIV-positive persons were detected.

          Conclusion

          MSM drive the HIV epidemic in Cuba. The extensive HIV testing policy may be an important factor in explaining the low HIV prevalence. To reduce the HIV epidemic in Cuba, the epidemic among MSM should be addressed. To understand this epidemic further, data on sexual behaviour should be collected. Now that antiretroviral therapy is more widely available, the Cuban policy, based on intensive HIV testing and tracing of partners, may be considered as a possible policy to control HIV/AIDS epidemics in other countries.

          Related collections

          Most cited references13

          • Record: found
          • Abstract: not found
          • Article: not found

          A serostatus-based approach to HIV/AIDS prevention and care in Africa.

            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Controlling AIDS in Cuba. The logic of quarantine.

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Cuba's response to the HIV epidemic.

              Cuba's response to the human immunodeficiency virus (HIV) epidemic has been to conduct mass testing of the population to ascertain seroprevalence, to enforce mandatory relative quarantine of persons testing positive, and to implement educational interventions using media and school-based programs. Interview with the Vice-Minister of Health and review of available data. Reports to date show a very low seroprevalence rate without evidence of a widespread epidemic. Sexual contact with foreign-born persons is the primary risk factor. Possible advantages of Cuba's policy include rapid reduction in the risk of HIV transmission by infected blood products, an opportunity for focused education and secondary prevention, and limitation of new infections. Possible disadvantages include the restriction of individual freedom in those who are not guilty of any illegal act, quarantine of persons with false positive HIV tests, and ongoing transmission because of the incomplete nature of the quarantine. The policy is expensive and may displace other public health priorities. The content of the media-based educational interventions has emphasized rational medical information in unimaginative formats with a limited focus on prevention. The issue of personal responsibility for behavioral change versus government imposed regulations is at the core of Cuba's HIV policy. The quarantine policy may paradoxically permit most Cubans to feel that they are personally invulnerable to the HIV epidemic.
                Bookmark

                Author and article information

                Journal
                BMC Infect Dis
                BMC Infectious Diseases
                BioMed Central
                1471-2334
                2007
                9 November 2007
                : 7
                : 130
                Affiliations
                [1 ]Facultad de Matematica y Computacion, Universidad de La Habana, La Habana, Cuba
                [2 ]Ministerio de Salud Publica, La Habana, Cuba
                [3 ]Université René Descartes, Laboratoire MAP5, UMR-CNRS 8145, Paris, France
                [4 ]Modalx – Université Paris X Nanterre; LPMA – UMR CNRS 7599 – Universités Paris 6 and Paris 7, France
                [5 ]Instituto de Medicina Tropical «Pedro Kouri», La Habana, Cuba
                [6 ]INSERM U687, 14 rue du Val d'Osne 94415 Saint-Maurice, France
                [7 ]Hôpital Ambroise Paré, Boulogne-Billancourt, France
                [8 ]Université de Versailles – Saint-Quentin; UFR médicale Paris-Ile-de-France-Ouest, Garches, France
                Article
                1471-2334-7-130
                10.1186/1471-2334-7-130
                2190762
                17996109
                73060a4e-5776-459b-a83e-6dc381cc3581
                Copyright © 2007 de Arazoza et al; licensee BioMed Central Ltd.

                This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

                History
                : 4 April 2007
                : 9 November 2007
                Categories
                Research Article

                Infectious disease & Microbiology
                Infectious disease & Microbiology

                Comments

                Comment on this article